Tyra Biosciences, Inc. (TYRA)
34.97
-0.30
(-0.85%)
USD |
NASDAQ |
Apr 15, 16:00
34.97
0.00 (0.00%)
After-Hours: 20:00
Tyra Biosciences Research and Development Expense (Annual) : 102.38M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Spyre Therapeutics, Inc. | 171.65M |
| Entrada Therapeutics, Inc. | 136.47M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| Agios Pharmaceuticals, Inc. | 334.36M |